Nyumbani › Magonjwa ya Mapafu › Texas › Houston
Majaribio ya kliniki ya Magonjwa ya Mapafu katika Houston, TX
Masomo 15 ya Magonjwa ya Mapafu yanatafuta washiriki katika vituo vya Houston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study of COVID-19 Vaccine(s) in Children and Adults
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
- DM Clinical Research-Cyfair, Houston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
InaajiriHatua 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- na zaidi ya 4
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
InaajiriHatua 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- na zaidi ya 4
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
InaajiriHatua 2
- Baylor College of Medicine Medical Center, Houston
American Lung Association (ALA) Lung Health Cohort
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Baylor College of Medicine, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
InaajiriHatua 1/2
- MD Anderson, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
InaajiriHatua 2
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
InaajiriHatua 1/2
- Site 1005, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
InaajiriHatua 3
- GSK Investigational Site, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
InaajiriHatua 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
InaajiriHatua 2
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
InaajiriHatua 2
- Clinical Research Site, Houston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
InaajiriHatua 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
InaajiriHatua 1/2
- MD Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Inaajiri
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Majaribio ya Magonjwa ya Mapafu katika miji mingine
- Boston, MAUtafiti 14
- Durham, NCUtafiti 13
- New York City, NYUtafiti 12
- Pittsburgh, PAUtafiti 11
- Columbus, OHUtafiti 10
- Nashville, TNUtafiti 10
- Dallas, TXUtafiti 10
- Los Angeles, CAUtafiti 10
- Washington, DCUtafiti 10
- Miami, FLUtafiti 10
- Ann Arbor, MIUtafiti 10
- Chicago, ILUtafiti 9
Masomo mengine katika Houston
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 145
- Saratani ya MatitiUtafiti 126
- Saratani (aina zote)Utafiti 121
- Saratani ya MetastasiUtafiti 104
- Kansari ya kolorektaliUtafiti 102
- Kansari ya MayaiUtafiti 89
- Leukemia ya Myeloid ya GhaflaUtafiti 85
- Saratan ya MapafuUtafiti 78
- Saratani ya ProstateUtafiti 76
- Saratani ya EndometrialUtafiti 68
- Kansari ya PancreasUtafiti 61
- MelanomaUtafiti 59
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.